DC Circ. Unsure If Rebate Rule Hurt Radioactive Drug Makers

A D.C. Circuit panel on Thursday questioned whether a trade association has established that its members have been injured by the federal government's determination that radiopharmaceutical products are outpatient drugs covered...

Already a subscriber? Click here to view full article